11:35 AM EST - Sernova Corp. : reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System. Interim results confirmed that the Cell Pouch System establishes a biological environment capable of preserving the functionality of therapeutic cells. The results also confirmed the Cell Pouch System allows for safe and efficacious cell-based therapy and may offer a revolutionary improvement over the current practice of injecting therapeutic cells into blood vessels. The Cell Pouch System is a proprietary medical device, implanted below the skin, allowing for incorporation of tissue and microvasculature to form an organ-like structure, establishing an environment for the survival and functionality of therapeutic cells. Sernova Corp.
shares V.SVA are trading even at $0.14.
